Revenue
$1.35B
Fiscal year ended 2026-03-31Operating income
$72.54M
Fiscal year ended 2026-03-31Free cash flow
-$21.16M
Fiscal year ended 2026-03-31Option Care Health, Inc. (OPCH) reported revenue of $1.35B and net income of $45.34M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Option Care Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.47B | $1.44B | $1.42B | $1.33B | $1.35B | $1.28B | $1.23B | $1.15B | $1.12B |
| Cost of revenue | $1.09B | $1.18B | $1.16B | $1.15B | $1.07B | $1.08B | $1.02B | $977.82M | $907.55M | $877.27M |
| Gross profit | $262.01M | $282.90M | $272.90M | $269.04M | $263.05M | $268.38M | $256.75M | $249.36M | $238.50M | $247.12M |
| Operating income | $72.54M | $91.50M | $84.51M | $82.71M | $79.19M | $87.04M | $85.09M | $80.68M | $69.03M | $84.56M |
| Net income | $45.34M | $58.50M | $51.82M | $50.52M | $46.74M | $60.13M | $53.86M | $53.04M | $44.79M | $57.18M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 158.21M | Unavailable | shares 163.09M | shares 164.13M | shares 166.80M | Unavailable | shares 171.94M | shares 174.09M | shares 175.62M | Unavailable |
| Pretax income | $61.00M | $81.52M | $68.97M | $68.86M | $63.56M | $81.05M | $73.55M | $72.04M | $56.96M | $78.92M |
| Income tax expense | $15.66M | $23.01M | $17.15M | $18.34M | $16.81M | $20.92M | $19.70M | $19.00M | $12.16M | $21.75M |
| Diluted EPS | $0.29 | Unavailable | $0.32 | $0.31 | $0.28 | Unavailable | $0.31 | $0.30 | $0.26 | Unavailable |
| Selling, general & administrative | $174.56M | $172.14M | $172.10M | $170.09M | $168.12M | $164.73M | $157.00M | $153.78M | $154.74M | $147.78M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $177.32M | $232.62M | $309.82M | $198.82M | $171.37M | $412.56M | $483.03M | $376.87M | $219.51M | $343.85M |
| Total assets | $3.38B | $3.46B | $3.48B | $3.38B | $3.31B | $3.42B | $3.43B | $3.35B | $3.25B | $3.22B |
| Current assets | $1.20B | $1.26B | $1.28B | $1.18B | $1.10B | $1.32B | $1.32B | $1.23B | $1.13B | $1.09B |
| Total liabilities | $2.03B | $2.13B | $2.12B | $2.02B | $1.96B | $2.02B | $2.00B | $1.94B | $1.82B | $1.80B |
| Current liabilities | $729.74M | $829.35M | $823.91M | $773.62M | $713.66M | $780.15M | $763.22M | $695.41M | $636.95M | $618.31M |
| Total equity incl. NCI | $1.35B | $1.33B | $1.36B | $1.36B | $1.35B | $1.40B | $1.43B | $1.41B | $1.43B | $1.42B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $415.69M | $471.15M | $415.72M | $403.54M | $369.03M | $388.13M | $310.60M | $281.42M | $241.95M | $274.00M |
| Accounts receivable | $516.44M | $473.57M | $474.50M | $481.25M | $476.65M | $409.73M | $428.95M | $468.30M | $573.65M | $377.66M |
| Goodwill | $1.61B | $1.61B | $1.61B | $1.61B | $1.61B | $1.54B | $1.54B | $1.54B | $1.54B | $1.54B |
| Long-term debt | $1.15B | $1.15B | $1.16B | $1.10B | $1.10B | $1.10B | $1.11B | $1.11B | $1.06B | $1.06B |
| Accounts payable | $545.02M | $639.83M | $627.87M | $590.22M | $528.85M | $610.78M | $591.97M | $535.69M | $485.74M | $426.51M |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$12.11M | $35.89M | $139.44M | $90.33M | -$7.21M | $36.12M | $160.40M | $195.66M | -$68.78M | $50.97M |
| Capital expenditures | $9.05M | $13.65M | $9.20M | $9.10M | $9.37M | $10.34M | $9.67M | $9.78M | $5.82M | $19.88M |
| Investing cash flow | -$9.32M | -$13.65M | -$11.72M | -$9.02M | -$126.69M | -$11.20M | -$9.67M | -$9.78M | -$5.82M | -$15.78M |
| Financing cash flow | -$33.87M | -$99.44M | -$16.71M | -$53.87M | -$107.29M | -$95.38M | -$44.58M | -$28.52M | -$49.73M | -$77.83M |
| Net change in cash | -$55.30M | -$77.20M | $111.00M | $27.45M | -$241.19M | -$70.46M | $106.15M | $157.36M | -$124.34M | -$42.64M |
| Stock-based compensation | $10.20M | $9.32M | $11.12M | $10.71M | $8.80M | $8.52M | $10.41M | $7.61M | $9.60M | $7.57M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | $95.06M | $62.46M | Unavailable | Unavailable | $92.60M | $42.00M | $78.07M | $40.05M | $75.15M |
| Depreciation & amortization | $14.91M | $20.32M | $16.29M | $16.24M | $15.75M | $17.47M | $14.66M | $14.91M | $14.73M | $14.78M |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$21.16M | $22.24M | $130.24M | $81.24M | -$16.58M | $25.78M | $150.73M | $185.88M | -$74.60M | $31.08M |
| Gross margin | 19.4% | 19.3% | 19.0% | 19.0% | 19.7% | 19.9% | 20.1% | 20.3% | 20.8% | 22.0% |
| Operating margin | 5.4% | 6.2% | 5.9% | 5.8% | 5.9% | 6.5% | 6.7% | 6.6% | 6.0% | 7.5% |
| FCF margin | -1.6% | 1.5% | 9.1% | 5.7% | -1.2% | 1.9% | 11.8% | 15.1% | -6.5% | 2.8% |
| SBC / revenue | 0.8% | 0.6% | 0.8% | 0.8% | 0.7% | 0.6% | 0.8% | 0.6% | 0.8% | 0.7% |
| Current ratio | 1.64x | 1.53x | 1.56x | 1.52x | 1.54x | 1.70x | 1.73x | 1.77x | 1.77x | 1.77x |
| Revenue YoY growth | 1.3% | 8.8% | 12.2% | 15.4% | 16.3% | 19.7% | 17.0% | 14.8% | 12.8% | 18.2% |
| Net margin | 3.4% | 4.0% | 3.6% | Unavailable | 3.5% | 4.5% | 4.2% | Unavailable | Unavailable | 5.1% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.7% | 0.9% | 0.6% | 0.6% | 0.7% | 0.8% | 0.8% | 0.8% | 0.5% | 1.8% |
| Long-term debt / equity | 0.85x | 0.87x | 0.85x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 25.7% | 28.2% | 24.9% | 26.6% | 26.5% | 25.8% | 26.8% | 26.4% | 21.4% | 27.6% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OPCH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-29View SEC filing
10-K · Filed 2025-02-26View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.